The Challenge of Incorporating High-Cost Technologies: An Analysis of PCSK9 Inhibitors. / O Desafio de Incorporar Tecnologias de Alto Custo: Uma Análise dos Inibidores de PCSK9.
Arq Bras Cardiol
; 117(5): 997-998, 2021 11.
Article
in En, Pt
| MEDLINE
| ID: mdl-34817009
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Proprotein Convertase 9
/
Anticholesteremic Agents
Type of study:
Health_economic_evaluation
Limits:
Humans
Language:
En
/
Pt
Journal:
Arq Bras Cardiol
Year:
2021
Document type:
Article